<DOC>
	<DOCNO>NCT01149421</DOCNO>
	<brief_summary>The purpose study assess effect 2 dos LY2189265 blood pressure heart rate use 24-hour ambulatory blood pressure monitoring ( ABPM ) , participant type 2 diabetes mellitus treat oral antihyperglycemic medication ( OAMs ) .</brief_summary>
	<brief_title>A Study Effect LY2189265 Blood Pressure Heart Rate Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dulaglutide</mesh_term>
	<criteria>Type 2 diabetes take 1 oral diabetes medication take medication least 1 month prior screen Glycosylated hemoglobin ( HbA1c ) value ≥7 % ≤9.5 % screening Mean blood pressure &gt; 90/60 millimeter mercury ( mmHg ) &lt; 140/90 mmHg screen If treat hypertension , take 3 less antihypertensive medication take medication least 1 month prior screen Stable weight 3 month prior screen Body mass index ( BMI ) great equal 23 kilogrammeter square ( kg/m^2 ) Willing wear ambulatory blood pressure monitor device least 24 hour multiple occasion Women childbearing potential must test negative pregnancy willing use reliable method birth control Male participant must use reliable method birth control Myocardial infarction , stroke , hospitalization heart failure within 3 month prior screen , heart failure Class III IV screen Ongoing history frequent intermittent tachyarrhythmia Resting heart rate &lt; 60 beat per minute ( bpm ) &gt; 100 bpm screen Work rotate shifts work hour 2200 0700 Chronic insulin therapy Use glucagonlike peptide 1 ( GLP1 ) receptor agonist within 3 month prior screen , dipeptidylpeptidaseIV ( DPPIV ) inhibitor within 2 week prior screen Nondominant arm circumference &gt; 42 centimeter ( cm ) Use drug promote weight loss Chronic use systemic steroid Gastric empty abnormality bariatric surgery Hepatitis , liver disease , alanine transaminase ( ALT ) &gt; 3 time upper limit normal Acute chronic pancreatitis Severe renal impairment Active autoimmune disease uncontrolled endocrine abnormality Self family history thyroid cancer , medullary Ccell hyperplasia , type 2A 2B multiple endocrine neoplasia Calcitonin value great equal 20 picograms per milliliter ( pg/ml ) screening Transplanted organ except corneal transplant Active untreated cancer remission &lt; 5 year , except skin , situ cervical , prostate cancer Sicklecell disease , hemolytic anemia , another hematological condition may interfere HbA1c test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Ambulatory Blood Pressure Monitoring</keyword>
	<keyword>ABPM</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Heart Rate</keyword>
</DOC>